Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Güner, M Kalcik, AÇ Aykan, MO Gürsoy… - Blood Coagulation & …, 2020 - journals.lww.com
The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Güner, M Kalçik, AÇ Aykan, MO Gürsoy… - Blood Coagulation & …, 2020 - journals.lww.com
The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Güner, M Kalçik, AÇ Aykan, MO Gürsoy… - Blood Coagulation & …, 2020 - europepmc.org
: The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Güner, M Kalçık, AÇ Aykan, MO Gürsoy… - Blood Coagulation & …, 2020 - 79.123.184.155
The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Güner, M Kalçik, AÇ Aykan… - … & fibrinolysis: an …, 2020 - pubmed.ncbi.nlm.nih.gov
: The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Güner, M Kalçık, AÇ Aykan, MO Gürsoy… - Blood Coagulation & …, 2020 - earsiv.hitit.edu.tr
The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Guner, M Kalcik, A Aykan, M Gursoy… - BLOOD …, 2020 - avesis.istanbul.edu.tr
The patients with intermediate-high risk pulmonary embolism who have acute right
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
ventricular (RV) dysfunction and myocardial injury without overt hemodynamic compromise …
[PDF][PDF] Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk …
A Guner, M Kalcık, AC Aykan, MO Gursoy… - Blood Coagulation and …, 2020 - emcrit.org
Introduction Acute pulmonary embolism is a life-threatening disorder which usually presents
as a severe complication of venous thromboembolism [1]. The pulmonary embolism is …
as a severe complication of venous thromboembolism [1]. The pulmonary embolism is …